- cancer genetics
- prostate cancer treatment and screening
Professor Eeles has both a private and an NHS practice at The Royal Marsden. She trained at the University of Cambridge and St Thomas’ Hospital Medical School. She then underwent higher medical training and is a fellow of the Royal College of Physicians of London. She trained in clinical oncology at The Royal Marsden and is a fellow of the Royal College of Radiologists (Clinical Oncology Faculty), UK.
Her research training was in genetic predisposition to cancer at The Institute of Cancer Research (ICR) and she has a PhD in Cancer Genetics from the University of London. She spent a year in the United States where she worked in research in cancer genetics and had oncology clinical experience.
She now leads a programme of research at the ICR in genetic predisposition to prostate cancer and management of individuals with BRCA and other repair gene mutations. She is an author on over 400 papers and has edited a major textbook on genetic predisposition to cancer.
Professor Eeles is accredited in clinical oncology with a sub-specialism in cancer genetics – cancer risk assessment, genetic testing for predisposition to cancer, targeted screening advice based on cancer genetic risk assessment and the application of cancer genetics to cancer care. She does not undertake gene therapy.
She has been on several genetics advisory committees and edited the special edition of Familial Cancer ‘Delivering cancer genetics services – new ways of working’ which reported on models of delivery of cancer genetics services. Her clinical oncology practice is in urological oncology. She is the Genomics Champion for the Royal College of Radiologists (Clinical Oncology Faculty) to the Academy of Royal Colleges. Her book which she led as lead editor ‘Cancer Prevention and Screening’ won the BMA Chairman’s Book of the Year Award in 2019.